GeminIQ Website Logo

Viewing BICX free

Subscribe for full history, 50+ metrics, screener, watchlist...

BioCorRx Inc.

BICX

Companies in Services-Specialty Outpatient Facilities, NEC

BioCorRx Inc. (BICX) — SEC Financial Statements & Analysis

BioCorRx Inc. (BICX) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Cash And Cash Equivalents At Carrying Value
000000000000
Accounts Receivable Net
-----------0
Assets
Cash
-----------0
Accounts Receivable Net Current
00000000000-
Grants Receivable
----00000000
Grants Receivable Current
0010-0------
Inventory Net
000000------
Assets Current
Assets Current
111110000000
Prepaid Expense Current
000000000000
Property Plant And Equipment Net
000000000000
Finite Lived Intangible Assets Net
-1---000000-
Capitalized Software Development Costs For Softwar…
----------00
Long Term Investments
-----------0
Operating Lease Right Of Use Asset
000000000000
Other Assets
Other Assets
116660000000
Other Intangible Assets Net
113330------
Goodwill
113330------
Deposit Assets
----0000000-
Deposits Assets Noncurrent
0000-0------
Development Costs Cumulative
---------0--
Assets
228770100011
Liabilities And Stockhold…
Accounts Payable And Accrued Liabilities Current
761212116655544
Deferred Revenue Current
-000-0---000
Liabilities Current
Derivative Liabilities
-----00000--
Liabilities Current
981515138877666
Operating Lease Liability Current
000000000000
Notes Payable Current
112211111100
Other Long Term Debt Noncurrent
--0---------
Liabilities Noncurrent
Economic Injury Disaster …
Construction Loan Noncurrent
0-----------
Accrued Royalties Current And Noncurrent
0000-0------
Contractual Obligation
55---444444-
Deferred Revenue Noncurrent
-----0000000
Operating Lease Liability Noncurrent
000000000000
Liabilities
14142020191313121110109
Stockholders Equity
Preferred Stock No Par Va…
Commitments And Contingen…
Preferred Stock Value
--0---------
Common Stock Value
000000000000
Common Stock Shares Subscriptions
000000000000
Additional Paid In Capital
767574737271706968686868
Retained Earnings Accumulated Deficit
-87-87-87-85-84-83-82-81-79-78-77-76
Stockholders Equity
-12-11-13-13-12-12-12-11-11-10-9-9
Minority Interest
-0-01-0-0-0-0-0-0-0-0-0
Liabilities And Stockholders Equity
228770100011
Preferred Stock Par Or Stated Value Per Share
-----0---00-
Preferred Stock Shares Authorized
111111111111
Common Stock Par Or Stated Value Per Share
0.0010.0010.0010.0010.310.0010.750.0010.0010.0010.0010.001
Preferred Stock No Par Value
------000---
Common Stock Shares Authorized
750750750750750750750750750750750750
Common Stock Shares Issued
29242017171311109999
Shares Outstanding
292411171713112018171717
Preferred Stock Shares Issued
-----------0
Preferred Stock Shares Outstanding
-----------0

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-23.64%-31.31%----------
202515.76%15.76%53.70%-29.58%12.47%7.82%-22.32%-35.04%-33.04%1.75%0.00%-17.50%
2024-13.58%-32.10%-34.07%-23.52%-28.74%-28.74%13.04%10.14%4.06%-42.37%-39.76%-31.73%
2023---2.44%2.44%-3.66%-8.13%-42.28%-39.02%-16.20%-12.85%-44.13%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Performance and Valuation Metrics

Metrics
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
0.12
0.10
0.10
0.04
0.04
0.01
0.04
0.02
0.02
0.03
0.04
0.08
Quick Ratio
0.08
0.05
0.08
0.02
0.03
0.01
0.04
0.02
0.02
0.02
0.03
0.05
Working Capital
-7.51M
-7.49M
-13.58M
-14.03M
-12.88M
-8.09M
-7.87M
-7.14M
-7.02M
-6.24M
-5.70M
-5.27M
Leverage & Debt
Debt to Equity
-1.20
-1.19
-1.59
-1.51
-1.58
-1.03
-1.05
-1.04
-1.03
-1.04
-1.06
-1.09
Interest Coverage TTM
-28.97
-21.58
-19.23
-12.80
-7.46
-6.59
-6.41
-6.44
-10.58
-19.52
-36.36
-46.41
Debt Ratio
6.00
6.37
2.69
2.95
2.74
33.01
19.65
24.30
35.24
26.59
18.33
12.51
Efficiency & Turnover
Asset Turnover TTM
0.19
0.63
0.25
0.11
0.06
0.25
0.09
0.06
0.10
0.15
0.23
0.29
Days Sales Outstanding TTM
92.06
116.04
70.17
46.55
179.57
-
-
-
-
73.93
29.12
-
Receivables Turnover TTM
3.96
3.15
5.20
7.84
2.03
-
-
-
-
4.94
12.53
-
Per Share Metrics
Diluted EPS TTM
-0.14
-0.19
-0.30
-0.30
-0.32
-0.50
-0.45
-0.36
-0.34
-0.35
-0.43
-0.51
Free Cash Flow Per Share TTM
-0.07
-0.09
-0.08
-0.08
-0.09
-0.08
-0.12
-0.07
-0.20
-0.21
-0.21
-0.21
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
112.68%
128.08%
127.87%
199.86%
399.86%
716.05%
965.83%
914.48%
44.63%
59.64%
79.35%
87.33%
Operating Profit Margin TTM
-553.06%
-606.04%
-536.12%
-1,278.40%
-2,237.30%
-5,318.99%
-9,230.03%
-11,218.64%
-7,069.76%
-4,248.31%
-2,711.21%
-1,776.84%
Net Profit Margin TTM
-401.07%
-440.11%
-533.94%
-1,236.92%
-2,120.70%
-5,412.02%
-9,428.79%
-11,712.85%
-7,630.77%
-4,224.89%
-2,589.45%
-1,705.22%
Growth Metrics
Net Revenue Growth (1Y)
285.30%
727.82%
1,836.54%
993.33%
334.84%
8.01%
-65.89%
-84.52%
-77.61%
-58.31%
5.90%
302.71%
Net Income Growth (1Y)
-27.13%
-32.68%
9.66%
15.46%
20.85%
38.37%
24.21%
6.33%
-10.10%
-13.94%
-10.21%
-16.14%
EPS Growth (1Y)
-57.40%
-63.44%
-39.10%
28.41%
-36.37%
-9.76%
-4.81%
-52.12%
-18.13%
-23.41%
-20.33%
-30.29%
Valuation Metrics
P/E TTM
-3.29
-2.03
-0.79
-1.23
-1.74
-0.97
-0.73
-2.15
-1.99
-1.80
-3.79
-3.60
P/B
-0.99
-0.62
-0.34
-0.47
-0.71
-0.41
-0.30
-0.83
-0.73
-0.68
-1.62
-1.67
P/S TTM
13.19
8.94
4.23
15.24
36.98
52.48
68.70
252.27
152.14
75.88
98.21
61.37
Market Cap
11.56M
7.13M
4.28M
6.12M
8.42M
5.05M
3.59M
9.27M
7.96M
6.77M
15.04M
14.57M
Enterprise Value
12.59M
8.21M
5.54M
7.56M
9.88M
6.42M
4.88M
10.26M
8.66M
7.31M
15.29M
14.73M
Calculated Values
Free Cash Flow TTM
-2.04M
-2.30M
-1.70M
-1.42M
-1.45M
-1.10M
-1.38M
-1.38M
-1.80M
-1.85M
-1.77M
-1.79M
Net Debt
1.03M
1.08M
1.26M
1.43M
1.47M
1.36M
1.29M
992.52K
701.87K
541.53K
251.83K
162.43K
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2024-01-16Purchase
Owner: Lucido, Louis C.
Title: Interim President
Shares: 126
Price/Share: $0.70
Value: $88.20
Shares Owned: 474,933
Relationship: Director,Officer,TenPercentOwner
Ownership: Direct
2023-04-03Purchase
Owner: Lucido, Louis C.
Title: -
Shares: 171,296
Price/Share: $1.75
Value: $299,768.00
Shares Owned: 276,279
Relationship: Director,TenPercentOwner
Ownership: Indirect
2023-03-29Purchase
Owner: Galligan, Joseph J
Title: -
Shares: 171,296
Price/Share: $1.75
Value: $299,768.00
Shares Owned: 217,546
Relationship: Director,TenPercentOwner
Ownership: Indirect
2023-01-30Purchase
Owner: Lucido, Louis C.
Title: -
Shares: 400
Price/Share: $1.38
Value: $552.00
Shares Owned: 102,159
Relationship: Director,TenPercentOwner
Ownership: Direct
2023-01-26Purchase
Owner: Lucido, Louis C.
Title: -
Shares: 500
Price/Share: $1.29
Value: $645.00
Shares Owned: 101,759
Relationship: Director,TenPercentOwner
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2019-06-30
0.01%
Inst. Shares: 1,000
Shares Outstanding: 12,231,392
2018-12-31
0.97%
Inst. Shares: 101,000
Shares Outstanding: 10,389,388
2018-09-30
0.52%
Inst. Shares: 100,010
Shares Outstanding: 19,268,704
2018-06-30
0.57%
Inst. Shares: 110,000
Shares Outstanding: 19,268,704
2018-03-31
0.57%
Inst. Shares: 110,000
Shares Outstanding: 19,268,704

Research Faster.
Invest Smarter.

BioCorRx Inc. (BICX) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 50+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.